Spruce Biosciences

Spruce Biosciences is a clinical-stage biopharmaceutical company dedicated to developing new therapies for rare endocrine diseases. Their mission is to develop meaningful treatments for patients with rare disorders affecting the hypothalamic-pituitary-adrenal (HPA) axis ("stress pathway"). The company is committed to transforming the quality of life for patients who are underserved by scientific innovation.